Form 8-K - Current report:
SEC Accession No. 0001193125-26-056983
Filing Date
2026-02-18
Accepted
2026-02-18 16:00:26
Documents
10
Period of Report
2026-02-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K cue-20260218.htm   iXBRL 8-K 68023
  Complete submission text file 0001193125-26-056983.txt   199529

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20260218.xsd EX-101.SCH 46337
12 EXTRACTED XBRL INSTANCE DOCUMENT cue-20260218_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 26648050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)